ATE378321T1 - Pyrazolopyrimidine - Google Patents
PyrazolopyrimidineInfo
- Publication number
- ATE378321T1 ATE378321T1 AT05753794T AT05753794T ATE378321T1 AT E378321 T1 ATE378321 T1 AT E378321T1 AT 05753794 T AT05753794 T AT 05753794T AT 05753794 T AT05753794 T AT 05753794T AT E378321 T1 ATE378321 T1 AT E378321T1
- Authority
- AT
- Austria
- Prior art keywords
- cyclin
- pyrazolopyrimidines
- dependent kinase
- treatment
- control
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- APXRHPDHORGIEB-UHFFFAOYSA-N 1H-pyrazolo[4,3-d]pyrimidine Chemical class N1=CN=C2C=NNC2=C1 APXRHPDHORGIEB-UHFFFAOYSA-N 0.000 abstract 2
- 102000013701 Cyclin-Dependent Kinase 4 Human genes 0.000 abstract 2
- 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 108010034798 CDC2 Protein Kinase Proteins 0.000 abstract 1
- 101150012716 CDK1 gene Proteins 0.000 abstract 1
- 108091007914 CDKs Proteins 0.000 abstract 1
- 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 abstract 1
- 102100032857 Cyclin-dependent kinase 1 Human genes 0.000 abstract 1
- 102100036239 Cyclin-dependent kinase 2 Human genes 0.000 abstract 1
- 102000003903 Cyclin-dependent kinases Human genes 0.000 abstract 1
- 108090000266 Cyclin-dependent kinases Proteins 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 101150073031 cdk2 gene Proteins 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 208000029742 colonic neoplasm Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 208000037841 lung tumor Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000023958 prostate neoplasm Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57825304P | 2004-06-09 | 2004-06-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE378321T1 true ATE378321T1 (de) | 2007-11-15 |
Family
ID=35170008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05753794T ATE378321T1 (de) | 2004-06-09 | 2005-06-01 | Pyrazolopyrimidine |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7405220B2 (de) |
| EP (1) | EP1758871B1 (de) |
| JP (1) | JP2008501744A (de) |
| CN (1) | CN1964954B (de) |
| AT (1) | ATE378321T1 (de) |
| AU (1) | AU2005251892A1 (de) |
| BR (1) | BRPI0511975A (de) |
| CA (1) | CA2568722A1 (de) |
| DE (1) | DE602005003362T2 (de) |
| ES (1) | ES2296195T3 (de) |
| MX (1) | MXPA06014161A (de) |
| PL (1) | PL1758871T3 (de) |
| RU (1) | RU2412186C2 (de) |
| WO (1) | WO2005121107A1 (de) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007523938A (ja) * | 2004-02-27 | 2007-08-23 | エフ．ホフマン−ラ ロシュ アーゲー | ピラゾールの縮合誘導体 |
| KR100844864B1 (ko) * | 2004-02-27 | 2008-07-09 | 에프. 호프만-라 로슈 아게 | 헤테로아릴-융합 피라졸로 유도체 |
| KR101011956B1 (ko) * | 2005-08-25 | 2011-01-31 | 에프. 호프만-라 로슈 아게 | Ｐ３８ ｍαｐ 키나아제 저해제 및 이의 사용 방법 |
| US7705009B2 (en) * | 2005-11-22 | 2010-04-27 | Hoffman-La Roche Inc. | 4-aminopyrimidine-5-thione derivatives |
| NZ572381A (en) | 2006-04-28 | 2011-01-28 | Shionogi & Co | Amine derivative having npy y5 receptor antagonist activity |
| US8314234B2 (en) | 2006-09-25 | 2012-11-20 | Janssen Pharmaceutica N.V. | Bicyclic pyrimidine kinase inhibitors |
| MX2010001636A (es) * | 2007-08-14 | 2010-03-15 | Hoffmann La Roche | Derivados de pirazolo[3,4-d]-pirimidina como agentes antiproliferativos. |
| SA08290668B1 (ar) | 2007-10-25 | 2012-02-12 | شيونوجي آند كو.، ليمتد | مشتقات أمين لها نشاط مضاد لمستقبل npy y5 واستخداماتها |
| KR100963644B1 (ko) | 2007-11-23 | 2010-06-15 | 한국과학기술연구원 | 피라졸로피리미딘온 유도체 및 그의 제조방법 |
| US8220787B2 (en) * | 2008-09-19 | 2012-07-17 | Panasonic Corporation | Part mounting device |
| WO2010118367A2 (en) * | 2009-04-10 | 2010-10-14 | Progenics Pharmaceuticals, Inc. | Antiviral pyrimidines |
| US8227618B2 (en) | 2009-04-23 | 2012-07-24 | Shionogi & Co., Ltd. | Amine-derivatives having NPY Y5 receptor antagonistic activity and the uses thereof |
| US8362023B2 (en) | 2011-01-19 | 2013-01-29 | Hoffmann-La Roche Inc. | Pyrazolo pyrimidines |
| JP2013142065A (ja) | 2012-01-10 | 2013-07-22 | Sumitomo Chemical Co Ltd | 植物病害防除組成物およびその用途 |
| CN102690270B (zh) * | 2012-05-28 | 2014-02-05 | 苏州科捷生物医药有限公司 | 嘧啶类化合物及其用途 |
| CN103058934A (zh) * | 2013-01-07 | 2013-04-24 | 盛世泰科生物医药技术(苏州)有限公司 | 一种5-乙酰基-2,4-二氯嘧啶的合成方法 |
| TWI629275B (zh) | 2013-03-13 | 2018-07-11 | 賽諾菲公司 | Ｎ－（４－（氮雜吲唑－６－基）－苯基）－磺醯胺及其作為醫藥之用途 |
| RU2671494C2 (ru) | 2014-05-28 | 2018-11-01 | Шанхай Фокон Фармасьютикал Ко., Лтд | Некоторые ингибиторы протеинкиназы |
| JP6625649B2 (ja) * | 2015-01-23 | 2019-12-25 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ | ピラゾロ［３，４−ｄ］ピリミジン誘導体およびリーシュマニア症の処置のためのその使用 |
| GB201501115D0 (en) | 2015-01-23 | 2015-03-11 | Univ Dundee | Compounds |
| DE102016110830B4 (de) | 2015-06-14 | 2022-01-13 | Zema - Zentrum Für Mechatronik Und Automatisierungstechnik Gemeinnützige Gmbh | Vorrichtung zur Befestigung einer Adaptionsplatte an einer Radnabe eines Fahrzeugs und Verfahren zum Betrieb einer Adaptionsplatte an einer Radnabe eines Fahrzeugs |
| CN112313232B (zh) | 2018-05-02 | 2024-03-08 | Jw中外制药公司 | 新型杂环衍生物 |
| US11066404B2 (en) | 2018-10-11 | 2021-07-20 | Incyte Corporation | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors |
| US11384083B2 (en) | 2019-02-15 | 2022-07-12 | Incyte Corporation | Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors |
| TW202100520A (zh) | 2019-03-05 | 2021-01-01 | 美商英塞特公司 | 作為cdk2 抑制劑之吡唑基嘧啶基胺化合物 |
| WO2020205560A1 (en) | 2019-03-29 | 2020-10-08 | Incyte Corporation | Sulfonylamide compounds as cdk2 inhibitors |
| US11447494B2 (en) | 2019-05-01 | 2022-09-20 | Incyte Corporation | Tricyclic amine compounds as CDK2 inhibitors |
| US11440914B2 (en) | 2019-05-01 | 2022-09-13 | Incyte Corporation | Tricyclic amine compounds as CDK2 inhibitors |
| CN116348458A (zh) | 2019-08-14 | 2023-06-27 | 因赛特公司 | 作为cdk2抑制剂的咪唑基嘧啶基胺化合物 |
| CN119930611A (zh) * | 2019-10-11 | 2025-05-06 | 因赛特公司 | 作为cdk2抑制剂的双环胺 |
| US20230109839A1 (en) | 2020-01-07 | 2023-04-13 | Sumitomo Pharma Co., Ltd. | Therapeutic agent for tauopathies |
| AU2022271290A1 (en) | 2021-05-07 | 2023-11-23 | Kymera Therapeutics, Inc. | Cdk2 degraders and uses thereof |
| US11981671B2 (en) | 2021-06-21 | 2024-05-14 | Incyte Corporation | Bicyclic pyrazolyl amines as CDK2 inhibitors |
| CN117897384A (zh) * | 2021-06-28 | 2024-04-16 | 缆图药品公司 | Cdk2抑制剂 |
| EP4147700A1 (de) | 2021-09-08 | 2023-03-15 | LQT Therapeutics Inc. | N-(4-(azaindazol-6-yl)-phenyl)-sulfonamide zur verwendung bei der behandlung von sichelzellenkrankheit |
| US12084453B2 (en) | 2021-12-10 | 2024-09-10 | Incyte Corporation | Bicyclic amines as CDK12 inhibitors |
| US11976073B2 (en) | 2021-12-10 | 2024-05-07 | Incyte Corporation | Bicyclic amines as CDK2 inhibitors |
| WO2024238570A1 (en) * | 2023-05-15 | 2024-11-21 | Aleksia Therapeutics, Inc. | Cdk2 inhibitor pyrazolopyrimidine compounds |
| WO2025024726A1 (en) * | 2023-07-26 | 2025-01-30 | Kinnate Biopharma Inc. | Inhibitors of cyclin-dependent kinase |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9012592D0 (en) | 1990-06-06 | 1990-07-25 | Smithkline Beecham Intercredit | Compounds |
| US5654307A (en) * | 1994-01-25 | 1997-08-05 | Warner-Lambert Company | Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| UA66810C2 (uk) | 1997-10-27 | 2004-06-15 | Агорон Фармацевтикалз Інк. | Похідні 4-амінотіазолу та композиції на їх основі як інгібітори циклінозалежних кіназ |
| DE69837282T2 (de) * | 1997-12-13 | 2007-11-08 | Bristol-Myers Squibb Co. | VERWENDUNG VON PYRAZOLO Ä 3,4-bÜ PYRIDIN ALS CYCLIN-ABHÄNGIGE KINASE HEMMER |
| EP1058686B1 (de) * | 1998-02-25 | 2006-11-02 | Emory University | 2'-fluoronukleoside |
| DE69933680T2 (de) | 1998-08-29 | 2007-08-23 | Astrazeneca Ab | Pyrimidine verbindungen |
| GB9828511D0 (en) | 1998-12-24 | 1999-02-17 | Zeneca Ltd | Chemical compounds |
| KR20020027649A (ko) | 1999-09-15 | 2002-04-13 | 로즈 암스트롱, 크리스틴 에이. 트러트웨인 | 카이나제 억제제로서의 프테리딘온 |
| EP1235815A1 (de) | 1999-11-22 | 2002-09-04 | Warner-Lambert Company | Chinazoline und ihre verwendung als cyclin-dependent kinase enzym- inhibitoren |
| GB0004888D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
| GB0004886D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
| GB0004887D0 (en) | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
| BR0110302A (pt) | 2000-04-18 | 2003-01-14 | Agouron Pharma | Compostos de pirazol para inibição de proteìnas cinase, sal e pró-droga farmaceuticamente aceitável, metabólito farmaceuticamente ativo ou sal farmaceuticamente aceitável de metabólito, composição farmacêutica, método de tratamento de condição doentia em mamìferos mediada pela atividade de proteìna cinase, método de modulação ou inibição da atividade de um receptor de proteìna cinase |
| US6756374B2 (en) | 2001-01-22 | 2004-06-29 | Hoffmann-La Roche Inc. | Diaminothiazoles having antiproliferative activity |
| WO2002090360A1 (en) | 2001-05-10 | 2002-11-14 | Smithkline Beecham Corporation | Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases |
| ES2309206T3 (es) * | 2001-10-02 | 2008-12-16 | Smithkline Beecham Corporation | Compuestos quimicos. |
| US6818663B2 (en) | 2002-05-17 | 2004-11-16 | Hoffmann-La Roches | Diaminothiazoles |
| MXPA05001688A (es) * | 2002-08-12 | 2005-04-19 | Sugen Inc | 3-pirrolil-piridopirazoles y 3-pirrolil-indazoles como inhibidores de cinasa novedosos. |
| KR100468352B1 (ko) * | 2002-09-24 | 2005-01-27 | 한국과학기술연구원 | 신규 피라졸로피리미딘계 유도체, 그의 제조방법 및 이를 유효성분으로 하는 약학적 조성물 |
| US7157455B2 (en) | 2003-02-10 | 2007-01-02 | Hoffmann-La Roche Inc. | 4-Aminopyrimidine-5-one derivatives |
| US20070179161A1 (en) | 2003-03-31 | 2007-08-02 | Vernalis (Cambridge) Limited. | Pyrazolopyrimidine compounds and their use in medicine |
| KR100844864B1 (ko) * | 2004-02-27 | 2008-07-09 | 에프. 호프만-라 로슈 아게 | 헤테로아릴-융합 피라졸로 유도체 |
-
2005
- 2005-05-24 US US11/136,023 patent/US7405220B2/en not_active Expired - Fee Related
- 2005-06-01 PL PL05753794T patent/PL1758871T3/pl unknown
- 2005-06-01 MX MXPA06014161A patent/MXPA06014161A/es active IP Right Grant
- 2005-06-01 JP JP2007526250A patent/JP2008501744A/ja active Pending
- 2005-06-01 WO PCT/EP2005/005896 patent/WO2005121107A1/en not_active Ceased
- 2005-06-01 AT AT05753794T patent/ATE378321T1/de not_active IP Right Cessation
- 2005-06-01 EP EP05753794A patent/EP1758871B1/de not_active Expired - Lifetime
- 2005-06-01 CA CA002568722A patent/CA2568722A1/en not_active Abandoned
- 2005-06-01 BR BRPI0511975-8A patent/BRPI0511975A/pt not_active IP Right Cessation
- 2005-06-01 AU AU2005251892A patent/AU2005251892A1/en not_active Abandoned
- 2005-06-01 DE DE602005003362T patent/DE602005003362T2/de not_active Expired - Lifetime
- 2005-06-01 RU RU2007100134/04A patent/RU2412186C2/ru not_active IP Right Cessation
- 2005-06-01 CN CN200580018657XA patent/CN1964954B/zh not_active Expired - Fee Related
- 2005-06-01 ES ES05753794T patent/ES2296195T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1758871B1 (de) | 2007-11-14 |
| MXPA06014161A (es) | 2007-01-29 |
| AU2005251892A1 (en) | 2005-12-22 |
| BRPI0511975A (pt) | 2008-01-22 |
| US20050277655A1 (en) | 2005-12-15 |
| PL1758871T3 (pl) | 2008-04-30 |
| RU2007100134A (ru) | 2008-07-20 |
| JP2008501744A (ja) | 2008-01-24 |
| DE602005003362T2 (de) | 2008-10-16 |
| CN1964954B (zh) | 2010-07-21 |
| RU2412186C2 (ru) | 2011-02-20 |
| WO2005121107A1 (en) | 2005-12-22 |
| US7405220B2 (en) | 2008-07-29 |
| CA2568722A1 (en) | 2005-12-22 |
| DE602005003362D1 (en) | 2007-12-27 |
| CN1964954A (zh) | 2007-05-16 |
| EP1758871A1 (de) | 2007-03-07 |
| ES2296195T3 (es) | 2008-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0511975A (pt) | pirazolopirimidinas | |
| NO20071794L (no) | Disubstituerte pyrazolobenzodiazepiner nyttige som inhibitorer for CDK2 og angiogenese, og for behandling av bryst, tarm, lunge og prostata cancer | |
| IL191832A (en) | Pyridiazinone compounds and their use in the preparation of drugs for the treatment of tumors | |
| ATE470668T1 (de) | Pyrazolopyrimidine als inhibitoren von cyclinabhängiger kinase zur behandlung von krebs | |
| BRPI0409366A (pt) | compostos de pirimido | |
| CY1112400T1 (el) | Παραγωγα πυραζολοπυριμιδινης ως αναστολεις της εξαρτωμενης απο κυκλινη κινασης | |
| BRPI0616987A2 (pt) | pirazolopirimidinas como inibidores de cinase dependente de ciclina | |
| BR0315912A (pt) | Compostos pirimìdicos com atividade antiproliferativa (ii) | |
| CL2008001364A1 (es) | Uso de compuestos derivados de imidazol(1,2-b) piridazina y pirazolo(1,5-a) pirimidina inhibidores de tirosina quinasa pi-para tratar tumor benigno o maligno, entre otros; compuestos dereivados de imidazol(1,2-b)piridazina y pirazolo(1,5-a)pirimidina; composiciones farmaceuticas; y metodo de preparacion de compuestos. | |
| BRPI0314001B8 (pt) | pirazolopirimidinas como inibidores de cinase dependente de ciclina e composição farmacêutica compreendendo as mesmas | |
| MX2009005011A (es) | Imidazopirazinas como inhibidores de proteina quinasa. | |
| MX2010005950A (es) | 2-fluoropirazolo[1,5-a]pirimidinas como inhibidores de proteina quinasa. | |
| MX2010005300A (es) | 4-pirazolil-n-arilpirimidin-2-aminas y 4-pirazolil-n-heteroarilpir imidin-2-aminas como inhibidores de cinasas janus. | |
| TNSN08020A1 (en) | 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them | |
| BR0009887A (pt) | Pirazolbenzodiazepinas como inibidores de cdk2 | |
| NO20075849L (no) | Fremgangsmater og preparater til behandling eller forebygging av kreft | |
| CY1110666T1 (el) | Πυραζολοπυριμιδινες καταλληλες για θεραπεια καρκινικων νοσων | |
| ATE478852T1 (de) | Neue 4-cyano-, 4-amino-, und 4- aminomethylderivative von pyrazoloä1,5- aüpyridinen, pyrazoloä1,5-cüpyrimidinen und 2h- indazolverbindungen und 5-cyano-, 5-amino- und 5- aminomethylderivative von imidazoä1,2-aüpyridinen,und imidazoä1,5-aüpyrazinverbindungen als inhibitoren der cyclinabhänggen kinase | |
| EA200701930A1 (ru) | Производные пиримидина для лечения гиперпролиферативных нарушений | |
| MX2024013266A (es) | Compuestos de 6-(pirimidin-4-il)quinolina sustituidos como inhibidores de la cinasa dependiente de ciclina | |
| ATE502025T1 (de) | Arylcarboxamide und ihre verwendung als antitumormittel | |
| EA200501233A1 (ru) | 4-аминопиримидин-5-он | |
| Dugar et al. | Synthesis and evaluation of pyrrolotriazine based molecules as PI3 kinase inhibitors | |
| ATE435224T1 (de) | Neue piperidinsubstituierte diaminothiazole | |
| WO2009047216A3 (en) | Use of indolocarbazole imides as protein kinase inhibitors for the treatment of hematologic and solid tumors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1758871 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |